[Beta-blockers in the treatment of systolic dysfunction after myocardial infarction. Closing the circle?].
Martínez Martínez
J A
JA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000188:drug therapy*; D000077261:Carvedilol; D002908:Chronic Disease; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use; D013599:Systole / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol